概述使用成本效益分析评估药物的挑战
Christopher J Edwards1, Brian L Erstad1
1Department of Pharmacy Practice & Science, University of Arizona R. Ken Coit College of Pharmacy, Tucson, AZ, USA.
The Annals of pharmacotherapy
|April 24, 2025
概括
处方药的成本效益分析 (CEA) 是普遍医疗保健系统的标准,但在美国是有限的. 挑战包括准确评估成本和效用值,特别是对于患有并发症的患者.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 健康 结果 研究 研究 结果
背景情况:
- 像澳大利亚这样的全民医疗系统经常对新药进行成本效益评估.
- 美国医疗保健系统在很大程度上缺乏国家一级的药物成本效益分析,只有疫苗评估等有限的例外.
研究的目的:
- 提供与使用成本效益分析 (CEA) 来评估处方药物相关的挑战概述.
- 在美国医疗保健系统的背景下,专门解决这些挑战.
主要方法:
- 这篇论文回顾了成本效益分析的原则,包括使用自然单位和实用测量,如质量调整寿命年 (QALYs).
- 它讨论了CEA参数评估的固有挑战,重点关注实用值及其对先前存在的健康状况的个体的影响.
- 探讨多重标准决策分析 (MCDA) 作为替代或补充方法的作用.
主要成果:
- 成本效益分析 (CUA) 的一个重大挑战是低估了与年龄相关的健康问题,残疾或并发症患者的效用值.
- 这些公用事业的减少不成比例地影响弱势群体,导致要求进行方法修订.
- 美国没有单一付款人制度,这加剧了对药物的全面经济评估的困难.
结论:
- 需要对成本效益分析进行修订,特别是在准确地描述效用值方面.
- 解决美国药物经济评估所面临的挑战,不仅需要方法调整,还需要进行系统性变革.
- 美国食品和药物管理局 (FDA) 使用多重标准决策分析 (MCDA) 来纳入更广泛的观点,但控制药物成本需要全系统改革.
更多相关视频
相关概念视频
01:22Dose-Response Relationship: Potency and Efficacy
4.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
27
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
27
01:12Analysis of Population Pharmacokinetic Data
195
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
195
01:15Methods of Documentation VI: Case Management Model
541
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
541
01:26Pharmacokinetic Models: Comparison and Selection Criterion
20
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
20